| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00095 | 1 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.00064 | 1 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.00072 | 1 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.00055 | 1 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.00035 | 1 |